摘要:Sir , The publication by Ott et al. (1) restates the important, and topical, use of microbes in treating disease, in this case lymphoid immunodeficiencies. However, not everyone agrees that recombinant bacteria should be used in humans, and one particular submission to this journal called for a ban of such uses, a viewpoint that we wish to now strongly challenge (2).